Medtronic

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Medtronic 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MDT

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. 

CEO
Geoffrey Straub Martha
CEOGeoffrey Straub Martha
Employees
95,000
Employees95,000
Headquarters
Galway, Galway
HeadquartersGalway, Galway
Founded
2014
Founded2014
Employees
95,000
Employees95,000

MDT Key Statistics

Market cap
102.15B
Market cap102.15B
Price-Earnings ratio
21.54
Price-Earnings ratio21.54
Dividend yield
3.54%
Dividend yield3.54%
Average volume
14.18M
Average volume14.18M
High today
$80.85
High today$80.85
Low today
$79.44
Low today$79.44
Open price
$80.32
Open price$80.32
Volume
878.12K
Volume878.12K
52 Week high
$106.33
52 Week high$106.33
52 Week low
$73.31
52 Week low$73.31

Stock Snapshot

The current Medtronic(MDT) stock price is $79.57, with a market capitalization of 102.15B. The stock trades at a price-to-earnings (P/E) ratio of 21.54 and offers a dividend yield of 3.5%.

As of 2026-06-12, Medtronic(MDT) stock has fluctuated between $79.44 and $80.85. The current price stands at $79.57, placing the stock +0.2% above today's low and -1.6% off the high.

The Medtronic(MDT)'s current trading volume is 878.12K, compared to an average daily volume of 14.18M.

During the past year, Medtronic(MDT) stock moved between $73.31 at its lowest and $106.33 at its peak.

During the past year, Medtronic(MDT) stock moved between $73.31 at its lowest and $106.33 at its peak.

MDT News

TipRanks 3h
Medtronic price target lowered to $95 from $110 at BofA

BofA lowered the firm’s price target on Medtronic (MDT) to $95 from $110 and keeps a Buy rating on the shares. Noting that the firm’s services team continues to...

Zacks 1d
Medtronic Bets on Ablation, Robotics, and Hypertension - Zacks Investment Research

...

Medtronic Bets on Ablation, Robotics, and Hypertension - Zacks Investment Research
Simply Wall St 1d
What Medtronic's FDA-Cleared Nell-EQ Pulse Oximetry Platform Means For Shareholders

In early June 2026, Medtronic received FDA 510(k) clearance for its Nellcor pulse oximetry system with the Nell-EQ intelligent processor, aimed at delivering mo...

What Medtronic's FDA-Cleared Nell-EQ Pulse Oximetry Platform Means For Shareholders

Analyst ratings

64%

of 33 ratings
Buy
63.6%
Hold
36.4%
Sell
0%

More MDT News

TipRanks 2d
Top Medtronic Executive Makes Notable Move With Fresh Stock Sale

New insider activity at Medtronic ( (MDT) ) has taken place on June 9, 2026. Introducing TipRanks MCP for Agents Deliver institutional-grade market data directl...

The Motley Fool 4d
Why Medtronic Stock May Have Just Become the Best Buy in the Entire Healthcare Sector

Investing in healthcare hasn't been all that exciting an option for investors in recent years. But over the long term, it can lead to significant returns. Healt...

Why Medtronic Stock May Have Just Become the Best Buy in the Entire Healthcare Sector
Nasdaq 4d
Can Medtronic Finally Challenge Intuitive Surgical's Robotic Surgical Systems Dominance?

Key Points Medtronic's Hugo robotic-assisted surgery platform is approved in the U.S. for urologic procedures, and has more applications pending. Intuitive Su...

Can Medtronic Finally Challenge Intuitive Surgical's Robotic Surgical Systems Dominance?
Simply Wall St 6d
Medtronic Extends Corsano Wearable Deal To Deepen Digital Monitoring Story

Medtronic (NYSE:MDT) has expanded its partnership with Corsano Health for exclusive U.S. distribution of a medical grade, multi-parameter wearable. The device...

Medtronic Extends Corsano Wearable Deal To Deepen Digital Monitoring Story
TipRanks 7d
Medtronic: Balanced Risk-Reward Keeps Hold Rating as Analyst Slightly Lowers Price Target to $83

David Roman, an analyst from Goldman Sachs, maintained the Hold rating on Medtronic. The associated price target was lowered to $83.00. Unlock trusted, data-ba...

TipRanks 7d
Medtronic: Buy Rating Reaffirmed as Strong Execution Offsets Sector Multiple Compression and Price Target Trim to $97

In a report released yesterday, Lee Hambright from Bernstein maintained a Buy rating on Medtronic, with a price target of $97.00. Unlock trusted, data-backed i...

People also own

Based on the portfolios of people who own MDT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.